Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

• CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
• A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
• The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects
• ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
• PR3-AAV Resilient Remission or PRRR
• Efficacy and Safety of Partial Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
• Effect of Tofacitinib in Treating ANCA-associated Vasculitis
• Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
• Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
• Hydroxychloroquine in ANCA Vasculitis Evaluation
• Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
• Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
• Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
• Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
• Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
• Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab
• The Clinical Efficacy of DFPP in Patients With AAGN
• Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis
• Low-dose Glucocorticoid Vasculitis Induction Study
• Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
• Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
• Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
• Rituximab Vasculitis Maintenance Study
• CMV Modulation of the Immune System in ANCA-associated Vasculitis
• Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
• Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
• Efficacy Study of Two Treatments in the Remission of Vasculitis
• Abatacept in ANCA Associated Vasculitis
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
• WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
• MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
• Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
• Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
• Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)